Ivarmacitinib for the Treatment of Adults with Severe Alopecia Areata: Results from a Phase 3 Trial

Journal:

Journal of the American Academy of Dermatology

Published:

2025-09-23

DOI:

10.1016/j.jaad.2025.09.044

Affiliations:

22

Authors:

24

Go to article

Institutions	Authors	Share
Hengrui, China	3.000000	0.13
Peking University People's Hospital, PKUHSC, China	2.000000	0.08
Huashan Hospital, Fudan University, China	1.000000	0.04
The First Hospital of Jilin University, China	1.000000	0.04
The Third People's Hospital of Hangzhou, China	1.000000	0.04
Wuhan First Hospital, China	1.000000	0.04
Institute of Dermatology / Hospital for Skin Disease, CAMS & PUMC, China	1.000000	0.04
Beijing Tongren Hospital, Capital Medical University, China	1.000000	0.04
Xiangya Hospital, CSU, China	1.000000	0.04
Shenzhen People’s Hospital, China	1.000000	0.04
No.1 affiliated Hospital, ZCMU, China	1.000000	0.04
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China	1.000000	0.04
Second Xiangya Hospital, CSU, China	1.000000	0.04
Wuhan Union Hospital, HUST, China	1.000000	0.04
Dermatology Hospital of Jiangxi Province, China	1.000000	0.04
The First People's Hospital of Hangzhou, China	1.000000	0.04
Peking Union Medical College Hospital (PUMCH), China	1.000000	0.04
China-Japan Friendship Hospital, China	1.000000	0.04
Second Affiliated Hospital, AHMU, China	1.000000	0.04
Shanghai Dermatology Hospital (SDH), China	1.000000	0.04
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.04

Interested in Immunology?